CARTaGENE (CaG)
The CARTaGENE study consists of both a population-based biobank, and a prospective health study of over 20,000 adults aged between 40 and 69 at recruitment in Québec, Canada. The study was designed to be representative of metropolitan areas to facilitate translation into health promoting policies and interventions. Participants were randomly selected from health insurance registries, with information packages subsequently sent by mail and enrolment conducted over telephone calls.
Study design
Biobank, Cohort
Number of participants at first data collection
20,007 (participants)
Age at first data collection
40 - 69 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
Participants were randomly chosen to be broadly representative of the population of Quebec, Canada, based on provincial health insurance registries.
Sample features
Country
Year of first data collection
2009
Primary Institutions
Centre Hospitalier Universitaire (CHU) Sainte-Justine
Profile paper DOI
Funders
Genome Canada
Genome Québec
Ongoing?
Yes
Data types collected
- Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – online
- None
- None
- Healthcare data
Engagement
Keywords
Consortia and dataset groups
